InsiderSource
ZBH

ZIMMER BIOMET HOLDINGS, INC.

SEC CIK 1136869
$90.96 −6.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$413.2K
2 open-market
Net insider flow
−$413.2K
Net selling
Filings shown
18
Most recent
Revenue (FY2025)
$8.23B
+7.2% YoY
Net income (FY2025)
$705.1M
Reported
Total assets
$23.09B
Balance sheet
Source
SEC XBRL
From 10-K/10-Q
Advertisement

At a glance

Over the last 90 days, insiders at ZBH have sold a net $413.2K of stock (0 open-market buys vs 2 sells).

Largest recent trade: Yi Sang sold $347.1K of ZBH, trimming their stake 13%.

Most active filer: Winkler Lori, with 7 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ZBH, newest first
View on SEC EDGAR ↗
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Yi Sang · Group President, Asia Pacific · Open-market sale · filed 3w ago ΔOwn −13%

Yi Sang sold $347.1K of ZBH, trimming their stake 13%.

−$347.1K
4,200 sh @ $83
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Yi Sang · Group President, Asia Pacific · Open-market sale · filed 3w ago ΔOwn −2.9%

Yi Sang sold $66.1K of ZBH, trimming their stake 3%.

−$66.1K
800 sh @ $83
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Winkler Lori · SVP and CHRO · Open-market sale · filed Mar 16, 2026 ΔOwn −21%

Winkler Lori sold $250.8K of ZBH, trimming their stake 21%.

−$250.8K
2,650 sh @ $95
Advertisement
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Winkler Lori · SVP and CHRO · Open-market sale · filed Sep 10, 2025 ΔOwn −18%

Winkler Lori sold $156.2K of ZBH, trimming their stake 18%.

−$156.2K
1,500 sh @ $104
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Winkler Lori · SVP and CHRO · Open-market sale · filed Aug 20, 2025 ΔOwn −15%

Winkler Lori sold $153.7K of ZBH, trimming their stake 15%.

−$153.7K
1,500 sh @ $102
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Sell Winkler Lori · SVP and CHRO · Open-market sale · filed Mar 7, 2025 ΔOwn −14%

Winkler Lori sold $150.6K of ZBH, trimming their stake 14%.

−$150.6K
1,443 sh @ $104
ZBH
ZIMMER BIOMET HOLDINGS, INC.
Buy HAGEMANN ROBERT · Director · Open-market purchase · filed Aug 30, 2023 ΔOwn +100%

Hagemann Robert, ZBH's Director, spent $233K of their own money on 2,000 shares at $116, growing their stake 100%.

+$233K
2,000 sh @ $116
Advertisement

About ZBH insider activity

This page tracks every recent Form 4 filed for ZIMMER BIOMET HOLDINGS, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ZBH insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for ZIMMER BIOMET HOLDINGS, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.